Skip to main content

Published locations for FDA places partial hold on trials after secondary lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA places partial hold on trials after secondary lymphoma

User login

  • Reset your password
  • /content/fda-places-partial-hold-trials-after-secondary-lymphoma
  • /fedprac/article/164173/t-cell-lymphomas/fda-places-partial-hold-trials-after-secondary-lymphoma
  • /hematologynews/article/164173/t-cell-lymphomas/fda-places-partial-hold-trials-after-secondary
  • /oncologypractice/article/164173/t-cell-lymphomas/fda-places-partial-hold-trials-after-secondary
  • /fedprac/avaho/article/164173/t-cell-lymphomas/fda-places-partial-hold-trials-after-secondary
  • /hematologynews/nhlhub/article/164173/t-cell-lymphomas/fda-places-partial-hold-trials-after-secondary
  • /hematology-oncology/article/164173/t-cell-lymphomas/fda-places-partial-hold-trials-after-secondary
  • /b-cell-lymphoma-icymi/article/164173/t-cell-lymphomas/fda-places-partial-hold-trials-after-secondary